Status:

UNKNOWN

Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device

Lead Sponsor:

Seoul National University Hospital

Conditions:

Cardiovascular Complication

Eligibility:

All Genders

20+ years

Brief Summary

In patients undergoing surgery under general anesthesia, the clinical utility of non-invasive hemodynamic status monitoring equipment using HemoVista is compared with invasive hemodynamic status monit...

Detailed Description

For patients who are scheduled to monitor invasive blood pressure, invasive hemodynamic monitoring using FloTrac and additional HemoVista sensors are attached and output data are obtained at the same ...

Eligibility Criteria

Inclusion

  • Adult patients aged 20 or older who undergo surgery under general anesthesia for more than two hours
  • invasive close hemodynamic monitoring with FloTrac is needed

Exclusion

  • problems in site where HemoVista is attached

Key Trial Info

Start Date :

November 21 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05996965

Start Date

November 21 2023

End Date

December 30 2024

Last Update

November 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hee-Soo Kim

Seoul, Soul-t'ukpyolsi, South Korea, 03080